Status:
COMPLETED
Diabetes Mellitus and microRNA as Risk Factors for Mild Cognitive Impairment: Impact of Life Style Modification
Lead Sponsor:
National Research Centre, Egypt
Collaborating Sponsors:
Science and Technology Development Fund (STDF)
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
40-65 years
Phase:
NA
Brief Summary
This is a 2-step study; 1st step was a cross sectional study carried out on 163 consecutive Type 2 Diabetes Mellitus (T2DM) patients employee attending outpatient clinics of the National Research Cent...
Detailed Description
The current study was carried out during the period from February 2016 to June 2019 on two steps. 1\. First step (baseline assessment): It was a cross sectional study carried out on 163 Type 2 Diabet...
Eligibility Criteria
Inclusion
- T2DM patients attending outpatient clinics of Medical Services Unit of the National Research Center (NRC).
Exclusion
- T2DM patients with history of head trauma, stroke, transient ischemic attack, brain tumor, epilepsy, psychiatric disease, cardiac or liver failure and visual or hearing disabilities
Key Trial Info
Start Date :
February 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
163 Patients enrolled
Trial Details
Trial ID
NCT04891887
Start Date
February 1 2016
End Date
June 1 2019
Last Update
May 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Research Centre
Giza, Egypt